regulations

Final Ecommerce Law Passed, Effective January 2019

Final Ecommerce Law Passed, Effective January 2019

The Standing Committee of the National People’s Congress passed China’s Ecommerce Law on August 31, creating a framework for regulating China’s rapidly growing ecommerce market. The law takes effect January 1, 2019. Guidance on implementation of the law, as well as for cross-border ecommerce, will be released later.

Tags

State Council Legislative Priorities Highlight Key Issues for 2018

State Council Legislative Priorities Highlight Key Issues for 2018

The General Office of the State Council’s legislative work plan for 2018 indicates that several policies affecting foreign companies may be revised this year, including foreign investment restrictions, ecommerce, tax, and environmental regulations.

Tags

How to Avoid Political Pitfalls on Corporate Websites

How to Avoid Political Pitfalls on Corporate Websites

Recent rebukes from Chinese regulators have prompted a review of corporate websites to ensure the classification of place names are consistent with international diplomatic protocol and Chinese regulations. In a survey to guests, Marriott International listed Hong Kong, Tibet, and Macao as separate countries as opposed to parts of China.

Tags

Policy initiatives to watch for in 2018: Agriculture, Healthcare and Intellectual Property

Policy initiatives to watch for in 2018: Agriculture, Healthcare and Intellectual Property

To assist companies as they plan for the year ahead, US-China Business Council staff  compiled short summaries of the recent laws and regulations in China and those expected to be acted on in 2018. The first of this series of summaries focuses on agriculture, healthcare and intellectual property rights. Sectors covered in upcoming editions will cover information technology, financial services, energy and environment and automotive industry issues.  

Tags

IP

Sweeping Changes Underway for China’s Drug and Medical Device Approvals

Sweeping Changes Underway for China’s Drug and Medical Device Approvals

Hindered by redundancies in the approval process, problems securing suitable data for clinical trials, and disparities in the drug classification system between China and other countries, foreign companies have rarely found it easy to navigate China’s lengthy regulatory framework for approving pharmaceuticals and medical devices.

Tags

Subscribe to RSS - regulations